These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 20585451

  • 1. Immune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigen.
    del Rio B, Seegers JF, Gomes-Solecki M.
    PLoS One; 2010 Jun 18; 5(6):e11199. PubMed ID: 20585451
    [Abstract] [Full Text] [Related]

  • 2. Clonal diversification in OspA-specific antibodies from peripheral circulation of a chronic Lyme arthritis patient.
    Ghosh S, Huber BT.
    J Immunol Methods; 2007 Apr 10; 321(1-2):121-34. PubMed ID: 17307198
    [Abstract] [Full Text] [Related]

  • 3. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S, Yang X, Huang X, Dunn JJ, Luft BJ.
    J Mol Biol; 2005 Jul 08; 350(2):290-9. PubMed ID: 15935380
    [Abstract] [Full Text] [Related]

  • 4. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Izac JR, Oliver LD, Earnhart CG, Marconi RT.
    Vaccine; 2017 May 31; 35(24):3178-3185. PubMed ID: 28479174
    [Abstract] [Full Text] [Related]

  • 5. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA, De Luca K, Durand PY, Feilmeier B, DeWitt K, Sigoillot-Claude C, Sajous ML, Day MJ, David F.
    BMC Vet Res; 2018 Oct 16; 14(1):312. PubMed ID: 30326885
    [Abstract] [Full Text] [Related]

  • 6. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
    Wagner B, Freer H, Rollins A, Erb HN.
    Vet Immunol Immunopathol; 2011 Apr 15; 140(3-4):190-8. PubMed ID: 21208663
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector.
    Battisti JM, Bono JL, Rosa PA, Schrumpf ME, Schwan TG, Policastro PF.
    Infect Immun; 2008 Nov 15; 76(11):5228-37. PubMed ID: 18779341
    [Abstract] [Full Text] [Related]

  • 11. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula.
    Nassal M, Skamel C, Kratz PA, Wallich R, Stehle T, Simon MM.
    Eur J Immunol; 2005 Feb 15; 35(2):655-65. PubMed ID: 15668917
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of the recombinant bacterial outer surface protein A in tobacco chloroplasts leads to thylakoid localization and loss of photosynthesis.
    Hennig A, Bonfig K, Roitsch T, Warzecha H.
    FEBS J; 2007 Nov 15; 274(21):5749-58. PubMed ID: 17922845
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selective association of outer surface lipoproteins with the lipid rafts of Borrelia burgdorferi.
    Toledo A, Crowley JT, Coleman JL, LaRocca TJ, Chiantia S, London E, Benach JL.
    mBio; 2014 Mar 11; 5(2):e00899-14. PubMed ID: 24618252
    [Abstract] [Full Text] [Related]

  • 17. Platform technology to deliver prophylactic molecules orally: an example using the Class A select agent Yersinia pestis.
    del Rio B, Fuente JL, Neves V, Dattwyler R, Seegers JF, Gomes-Solecki M.
    Vaccine; 2010 Sep 24; 28(41):6714-22. PubMed ID: 20699130
    [Abstract] [Full Text] [Related]

  • 18. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R, Siebers A, Jahraus O, Brenner C, Stehle T, Simon MM.
    Infect Immun; 2001 Apr 24; 69(4):2130-6. PubMed ID: 11254567
    [Abstract] [Full Text] [Related]

  • 19. Production of outer surface protein A by Borrelia burgdorferi during transmission from infected mammals to feeding ticks is insufficient to trigger OspA seroconversion.
    Woodman ME, Cooley AE, Stevenson B.
    FEMS Immunol Med Microbiol; 2008 Nov 24; 54(2):277-82. PubMed ID: 18793197
    [Abstract] [Full Text] [Related]

  • 20. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR, Telford SR, Hu LT.
    Vaccine; 2006 Mar 10; 24(11):1949-57. PubMed ID: 16300863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.